
|Videos|May 30, 2017
Treatment of EGFR Mutant Non-Small Cell Lung Cancer
Treatment of EGFR Mutant Non-Small Cell Lung Cancer
Advertisement
- 65-year-old male, former smoker (25 pack-years, quit 12 years ago) presented complaining of persistent lower back pain, extreme fatigue, shortness of breath, and a 25-lb weight loss in the past 6 months.
- PMH includes rheumatoid arthritis which significantly limits his physical activity.
- Back pain also limited the patient’s daily activity.
- MRI of the spine showed evidence of multiple lesions, but none were causing cord compression.
- CT of the chest showed a 4-cm mass in the left lung, with enlarged bilateral mediastinal lymph nodes.
- The MRI of the brain revealed no metastases.
- ECOG PS was assessed to be 2.
- He underwent an endobronchial ultrasound-directed biopsy of the mediastinal lymph nodes.
- Pathology revealed poorly differentiated adenocarcinoma.
- Molecular testing showed a mutation in EGFR exon19 deletion.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Enfortumab Vedotin Plus Pembrolizumab Improves Survival in MIBC
2
Teclistamab/Daratumumab Earns FDA Priority Voucher for R/R Myeloma
3
Early Relapse Guides Use of CAR T vs Other Options in LBCL
4
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
5





































